{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:23:09Z","timestamp":1791296589835,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.kint.2016.10.040","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T01:04:44Z","timestamp":1484615084000},"page":"729-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies"],"prefix":"10.1016","volume":"91","author":[{"given":"Mark","family":"Haas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mirocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Reinsmoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jua","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Kahwaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Villicana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.10.040_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib2","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/00007890-199606150-00007","article-title":"Pathologic features of acute renal allograft rejection associated with donor-specific antibody","volume":"61","author":"Trpkov","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria \u2013 an addition to the Banff \u201997 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/TP.0b013e3181d368f1","article-title":"Significance and implications of capillaritis during acute rejection of renal allografts","volume":"89","author":"Cosio","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TP.0b013e3182777f28","article-title":"Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies","volume":"95","author":"Papadimitriou","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1600-6143.2011.03931.x","article-title":"A\u00a0new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants","volume":"12","author":"Sis","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib12","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib13","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1600-6143.2008.02303.x","article-title":"Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys","volume":"8","author":"Smith","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib14","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/j.1600-6143.2011.03647.x","article-title":"Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy","volume":"11","author":"Haas","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.TP.0000437177.40551.f4","article-title":"Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients","volume":"97","author":"Bagnasco","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2010070777","article-title":"Donor-specific antibodies accelerate arteriosclerosis after renal transplantation","volume":"22","author":"Hill","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib17","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-6143.2007.02104.x","article-title":"Transplant glomerulopathy","volume":"8","author":"Cosio","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib19","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1681\/ASN.2009020199","article-title":"Combination of peritubular capillary C4d and transplant glomerulopathy predicts late renal allograft failure","volume":"20","author":"Kieran","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib20","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1\u00a0year post-transplant and outcomes of kidney allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.TP.0000442513.27641.7e","article-title":"Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants","volume":"97","author":"Sharif","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib22","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib25","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1681\/ASN.2014111064","article-title":"Reassessing the significance of intimal arteritis in kidney transplant biopsy specimens","volume":"26","author":"Salazar","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal allograft recipients","volume":"96","author":"Dorje","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib29","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/TP.0000000000000525","article-title":"Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplantated into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00007890-199809270-00017","article-title":"Postransplant therapy using high-dose human immunoglobulin (intravenous immunoglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanisms of action","volume":"66","author":"Jordan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib33","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1681\/ASN.V12112482","article-title":"C4d-positive humoral renal allograft rejection: effective treatment by immunoadsorption","volume":"12","author":"Bohmig","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1600-6143.2006.01711.x","article-title":"Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study","volume":"7","author":"Mao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib35","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/S0041-1345(97)00680-5","article-title":"Renal transplant fibrosis: histomorphometric assessment of early renal transplant biopsies for markers of chronic rejection","volume":"29","author":"Nicholson","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2016.10.040_bib36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1600-6143.2005.00811.x","article-title":"Kidney allograft fibrosis and atrophy early after living donor transplantation","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-6143.2012.04304.x","article-title":"Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure","volume":"13","author":"Naesens","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.10.040_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2011040330","article-title":"Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy","volume":"23","author":"Berden","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/ctr.12345","article-title":"Histopathologic features of transplant glomerulopathy associated with response to therapy with IVIG and rituximab","volume":"28","author":"Kahwaji","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/TP.0b013e31825def05","article-title":"Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection","volume":"94","author":"Matignon","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e3181efcffd","article-title":"Determinants of long-term graft outcome in transplant glomeurlopathy","volume":"90","author":"John","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.10.040_bib43","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","article-title":"Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/ctr.12111","article-title":"The impact of C4d and microvascular inflammation before we knew them","volume":"27","author":"Verghese","year":"2013","journal-title":"Clinical Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2215\/CJN.07820910","article-title":"C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome","volume":"6","author":"Botermans","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.10.040_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ajt.13434","article-title":"Presentation and outcomes of C4d-negative antibody-mediated rejection after kidney transplantation","volume":"16","author":"Orandi","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib48","doi-asserted-by":"crossref","first-page":"e3094","DOI":"10.1097\/MD.0000000000003094","article-title":"Clinical significance of HLA-DQ antibodies in the development of chronic antibody-mediated rejection and allograft failure in kidney transplant recipients","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.kint.2016.10.040_bib49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1164\/rccm.201509-1857OC","article-title":"De novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation","volume":"194","author":"Tikkanen","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.kint.2016.10.040_bib50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/ajt.13551","article-title":"Identifying subphenotypes of antibody-mediated rejection in renal allografts","volume":"16","author":"Halloran","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib51","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1600-6143.2006.01356.x","article-title":"C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings","volume":"6","author":"Haas","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.10.040_bib52","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A\u00a0phase I\/II trial of the interleukin-6 receptor specific humanized monoclonal (tocilizumab)\u00a0+ intravenous immunoglobulin in difficult to sensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816306561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816306561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T21:37:16Z","timestamp":1658439436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816306561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0085253816306561"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.10.040","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}